ARTBIO
The Associate Director, CMC Development leads scientific and cross-functional teams to advance radiopharmaceutical programs from discovery through First-in-Human readiness. This role integrates radiochemistry, analytical sciences, and early CMC activities to drive technical strategy and manufacturing readiness for imaging and therapeutic assets. The position involves collaborating with internal departments and external partners to support regulatory submissions and clinical supply planning.
ARTBIO is a biotechnology company developing a new class of alpha radioligand therapies to redefine cancer care. The company is building an ecosystem — from targeted radioligand drug candidates and radiochemistry to manufacturing, clinical infrastructure, and partnerships — to maximize the potential of these potent targeted therapies. ARTBIO aims to accelerate development and broaden patient access by combining precision targeting, specialized delivery, and collaborative clinical programs.
ARTBIO Announces $132 Million Series B Financing to Advance Pipeline of Alpha Radioligand Therapies and Expand Manufacturing and Supply Chain Infrastructure
Jul 29, 2025
Jonathan Freeman, Ph.D. Joins ARTBIO as Chief Business Officer
Jan 6, 2026
Radiopharma startup Artbio secures $132M to fund testing of Pluvicto rival
Jul 29, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ARTBIO.
ARTBIO didn’t post a salary, so this is our estimate from similar listings.
Right around the average for this role
From CAR-T to RLT: Enhancing Precision Oncology with ARTBIO’s Radioligands
Aug 5, 2025
Advisor - Translational Radiochemistry
Eli Lilly and Company
Chief Attending, Radiochemistry & Imaging Sciences Service
Memorial Sloan Kettering Cancer Center
Director, CMC Technical Program Management
Perspective Therapeutics
CMC Lead
BeOne Medicines
Senior Director, Regulatory CMC
Perspective Therapeutics
Senior Director, CMC Product Leader (T1D)
Vertex